Related Experiment Video
Updated: Jun 3, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Associations Between Clinical Manifestations of SARS-CoV-2 Infection and HLA Alleles in a Caucasian Population: A
Bogusław Tymoniuk1, Maciej Borowiec2, Joanna Makowska3
1Department of Immunology and Allergy, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.
Insights
Certain human leukocyte antigen (HLA) alleles are linked to symptomatic COVID-19 and severe disease. Identifying these HLA profiles advances understanding of COVID-19
Area of Science:
- Immunogenetics
- Infectious Disease Epidemiology
Background:
- Severe COVID-19 remains a significant global health concern.
- The role of human leukocyte antigen (HLA) in immune responses necessitates investigating its impact on COVID-19 susceptibility and severity.
- Existing data on HLA and COVID-19 are inconsistent, highlighting the need for further research.
Purpose of the Study:
- To compare HLA profiles between patients with symptomatic SARS-CoV-2 infection and healthy controls.
- To analyze HLA allele frequencies in relation to COVID-19 severity (severe vs. non-severe).
Main Methods:
- Human leukocyte antigen (HLA) genotyping was performed using next-generation sequencing.
- The study included 2322 individuals: 2217 healthy hematopoietic stem cell donors and 105 patients with symptomatic COVID-19.
Main Results:
- Specific HLA alleles (e.g., HLA-A*30:01, HLA-B*44:02, HLA-DRB1*11:02) were associated with symptomatic SARS-CoV-2 infection.
- HLA alleles such as HLA-C*07:04 and HLA-DQB1*03:03 appeared to confer protection.
- The severe course of COVID-19 was linked to alleles including HLA-B*08:01, HLA-DRB1*03:01, and HLA-DQB1*03:01, whereas HLA-DRB1*08:01 showed a protective effect.
Conclusions:
- The study identified HLA alleles associated with symptomatic SARS-CoV-2 infection and severe COVID-19.
- These findings contribute to understanding the genetic underpinnings of COVID-19.
- This research is a step towards developing personalized medicine approaches for COVID-19 management.
Abstract:
Background and Objectives: Severe COVID-19 still constitutes an important health problem. Taking into account the crucial role of HLA in immune reactions, evaluation of the impact of HLA on COVID-19 risk and clinical course seemed necessary, as the already available data are inconsistent. The aim of the present study was to compare the HLA profiles of patients with symptomatic SARS-CoV-2 infection and a healthy control group, as well as to compare HLA allele frequencies in patients with severe and non-severe courses of COVID-19. Materials and Methods: HLA classes were genotyped using a next-generation sequencing method in 2322 persons, including 2217 healthy hematopoietic stem cell potential donors and 105 patients with symptomatic COVID-19. Results: Symptomatic course of SARS-CoV-2 infection appeared to be associated with the presence of HLA-A*30:01, B*44:02, B*52:01, C*05:01, C*17:01, and DRB1*11:02, while HLA-C*07:04 and DQB1*03:03 seem to play a protective role. Moreover, we demonstrated that the severe symptomatic course of COVID-19 can be associated with the presence of HLA-B*08:01, C*04:01, DRB1*03:01, and DQB1*03:01, while HLA-DRB1*08:01 appeared to be protective against severe COVID-19 disease. Conclusions: Identification of alleles that are potentially associated with symptomatic SARS-CoV-2 infection as well as the severe course of COVID-19 broadens the knowledge on the genetic background of COVID-19 course and can constitute an important step in the development of personalized medicine.
More Related Videos
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Multiple Allele Traits
Causality in Epidemiology